These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32916398)

  • 1. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
    de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
    Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
    Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
    Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
    Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
    Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage.
    Felton D; Foley EM; Traub SJ; Vodonos A; Ganetsky M
    J Emerg Med; 2016 Jan; 50(1):1-6. PubMed ID: 26409668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of routine head CT for hemorrhage surveillance in post-craniotomy patients undergoing anticoagulation for venous thromboembolism.
    Hacker E; Ozpinar A; Fernandes D; Agarwal N; Gross BA; Alan N
    J Clin Neurosci; 2021 Mar; 85():78-83. PubMed ID: 33581795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
    Rojas-Hernandez CM; Oo TH; García-Perdomo HA
    J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: Analysis of the prospective multicenter Consortium of Leaders in Traumatic Thromboembolism study.
    Wu YT; Chien CY; Matsushima K; Schellenberg M; Inaba K; Moore EE; Sauaia A; Knudson MM; Martin MJ;
    J Trauma Acute Care Surg; 2023 Nov; 95(5):649-656. PubMed ID: 37314427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review.
    Gorman J; Candeloro M; Schulman S
    Thromb Haemost; 2023 Oct; 123(10):966-975. PubMed ID: 37015326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
    Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
    J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.
    Senders JT; Goldhaber NH; Cote DJ; Muskens IS; Dawood HY; De Vos FYFL; Gormley WB; Smith TR; Broekman MLD
    J Neurooncol; 2018 Jan; 136(1):135-145. PubMed ID: 29039075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
    Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
    Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
    Jo J; Donahue J; Sarai G; Petroni G; Schiff D
    Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of long-term anticoagulation in patients with brain metastases.
    Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
    Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Becattini C; Cimini LA; Carrier M
    Thromb Res; 2021 Apr; 200():41-47. PubMed ID: 33529872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
    Zwicker JI; Karp Leaf R; Carrier M
    J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
    Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
    Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
    Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of early therapeutic anticoagulation following cranial surgery: an institutional case series.
    Davison MA; Patel AA; Lilly DT; Shost MD; Kashkoush AI; Krishnaney AA; Kshettry VR; Moore NZ; Rasmussen PA; Bain MD
    J Neurosurg; 2024 Oct; 141(4):1138-1146. PubMed ID: 38701530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
    Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
    Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.